These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 19193653)
1. Prediction of radiation pneumonitis following high-dose thoracic radiation therapy by 3 Gy/fraction for non-small cell lung cancer: analysis of clinical and dosimetric factors. Oh D; Ahn YC; Park HC; Lim DH; Han Y Jpn J Clin Oncol; 2009 Mar; 39(3):151-7. PubMed ID: 19193653 [TBL] [Abstract][Full Text] [Related]
2. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451 [TBL] [Abstract][Full Text] [Related]
3. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer. Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766 [TBL] [Abstract][Full Text] [Related]
4. [Low dose volume histogram analysis of the lungs in prediction of acute radiation pneumonitis in patients with esophageal cancer treated with three-dimensional conformal radiotherapy]. Shen WB; Zhu SC; Gao HM; Li YM; Liu ZK; Li J; Su JW; Wan J Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):45-9. PubMed ID: 23648300 [TBL] [Abstract][Full Text] [Related]
5. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy. Piotrowski T; Matecka-Nowak M; Milecki P Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028 [TBL] [Abstract][Full Text] [Related]
6. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Kim TH; Cho KH; Pyo HR; Lee JS; Zo JI; Lee DH; Lee JM; Kim HY; Hwangbo B; Park SY; Kim JY; Shin KH; Kim DY Radiology; 2005 Apr; 235(1):208-15. PubMed ID: 15703313 [TBL] [Abstract][Full Text] [Related]
7. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer. De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313 [TBL] [Abstract][Full Text] [Related]
8. Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel. Barriger RB; Fakiris AJ; Hanna N; Yu M; Mantravadi P; McGarry RC Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1381-6. PubMed ID: 20231061 [TBL] [Abstract][Full Text] [Related]
9. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy. Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164 [TBL] [Abstract][Full Text] [Related]
11. The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation. Ren C; Ji T; Liu T; Dang J; Li G Radiat Oncol; 2018 Apr; 13(1):69. PubMed ID: 29661254 [TBL] [Abstract][Full Text] [Related]
12. A study of ethnic differences in TGFβ1 gene polymorphisms and effects on the risk of radiation pneumonitis in non-small-cell lung cancer. Niu X; Li H; Chen Z; Liu Y; Kan M; Zhou D; Li Z; Ye X; Shen S; Lv C; Lu S J Thorac Oncol; 2012 Nov; 7(11):1668-75. PubMed ID: 23059779 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary dose-volume predictors of radiation pneumonitis following stereotactic body radiation therapy. Harder EM; Park HS; Chen ZJ; Decker RH Pract Radiat Oncol; 2016; 6(6):e353-e359. PubMed ID: 27156424 [TBL] [Abstract][Full Text] [Related]
14. Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: Dose-volume histogram analysis and comparison with conventional chemoradiation. Tsujino K; Hirota S; Kotani Y; Kado T; Yoden E; Fujii O; Soejima T; Adachi S; Takada Y Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1100-5. PubMed ID: 16373082 [TBL] [Abstract][Full Text] [Related]
15. Helical tomotherapy for solitary lung tumor: feasibility study and dosimetric evaluation of treatment plans. Tomita N; Kodaira T; Matsuo M; Furutani K; Tachibana H; Daimon T; Shimizu H Technol Cancer Res Treat; 2010 Aug; 9(4):407-15. PubMed ID: 20626206 [TBL] [Abstract][Full Text] [Related]
16. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer. Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230 [TBL] [Abstract][Full Text] [Related]
17. Comparison of risk and predictors for early radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with radiotherapy with or without surgery. Dang J; Li G; Zang S; Zhang S; Yao L Lung Cancer; 2014 Dec; 86(3):329-33. PubMed ID: 25454199 [TBL] [Abstract][Full Text] [Related]
18. The relationship between dosimetric factors, side effects, and survival in patients with non-small cell lung cancer treated with definitive radiotherapy. Okumus D; Sarihan S; Gozcu S; Sigirli D Med Dosim; 2017 Autumn; 42(3):169-176. PubMed ID: 28506589 [TBL] [Abstract][Full Text] [Related]
19. Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis. Katsui K; Ogata T; Watanabe K; Katayama N; Soh J; Kuroda M; Kiura K; Maeda Y; Toyooka S; Kanazawa S BMC Cancer; 2019 Nov; 19(1):1144. PubMed ID: 31771538 [TBL] [Abstract][Full Text] [Related]
20. Exclusion of emphysematous lung from dose-volume estimates of risk improves prediction of radiation pneumonitis. Uchida Y; Tsugawa T; Tanaka-Mizuno S; Noma K; Aoki K; Shigemori W; Nakagawa H; Kinose D; Yamaguchi M; Osawa M; Ogawa E; Nakano Y Radiat Oncol; 2017 Oct; 12(1):160. PubMed ID: 28969651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]